Ducord (HPC, Cord Blood)
Ducord (HPC, Cord Blood)
- Medicine Name: Ducord
- API: Hematopoietic Progenitor Cell, Cord Blood
- Dosage Form & Strength: Injectable Suspension for Intravenous Use
- Manufactured By: Duke University School of Medicine
Ducord (HPC, Cord Blood) is a type of therapy that uses hematopoietic progenitor cells derived from cord blood for transplantation. This allogeneic treatment involves using cord blood cells from an unrelated donor and is combined with a suitable preparative regimen to help rebuild the patient’s blood and immune systems. Ducord is used in patients who have conditions affecting their hematopoietic system, whether these conditions are inherited, acquired, or the result of myeloablative treatment.
Recommended Dosage: The minimum recommended dose of Ducord (HPC, Cord Blood) is 2.5 x 10^7 nucleated cells per kilogram of body weight at the time of cryopreservation. It may be necessary to use multiple units to reach the appropriate dose. It is advised to match at least 4 out of 6 HLA markers, including HLA-A antigens, HLA-B antigens, and HLA-DRB1 alleles. The HLA typing and nucleated cell count for each unit of Ducord (HPC, Cord Blood) are provided on the container label or in the accompanying documentation.
- Ducord may cause allergic reactions, including anaphylaxis. Patients with known hypersensitivity to any component of cord blood should not receive this product. Monitor for symptoms such as rash, itching, swelling, or difficulty breathing, and treat immediately if they occur.
- Infusion reactions, including fever, chills, nausea, vomiting, and headaches, may occur during or shortly after the administration of Ducord. Pre-medicate with antipyretics and antihistamines as needed and monitor closely during infusion.
- Ducord (Hematopoietic Progenitor Cell, Cord Blood)contains immune cells that may attack the recipient’s tissues, leading to graft-versus-host disease (GVHD). Monitor for signs such as rash, diarrhea, or liver dysfunction, and initiate treatment promptly if suspected.
- A condition named Engraftment Syndrome may occur post-transplant, presenting with fever, rash, and pulmonary symptoms. Early recognition and management with corticosteroids may be necessary.
- There is a risk of graft failure, where the transplanted cells do not function properly. Monitor blood counts and chimerism, and consider additional treatments if engraftment is inadequate.
- Ducord is screened for infectious agents, but the risk of disease transmission cannot be entirely ruled out. Monitor for signs of infection and follow up with appropriate testing.
- Although rare, there is a potential risk of transmitting genetic diseases present in the donor cord blood. Genetic counseling and testing may be considered.
- The safety of Ducord in pregnant or breastfeeding women has not been established. Use only if the potential benefits outweigh the risks. Consult healthcare providers for guidance.
What documents are required to import DUCORD to India?
DUCORD (HPC, Cord Blood) can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patient ID proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from the Doctor
- Import permit if applicable
Is DUCORD available in India?
DUCORD (HPC, Cord Blood) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Ducord (HPC, Cord Blood) in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
DUCORD can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
IPN (Indian Pharma Network) can facilitate the supply of DUCORD (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Ducord (HPC, Cord Blood) price in India.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
What is the Generic Name for the trade name drug Ducord®?
Hematopoietic Progenitor Cell, Cord Blood is a Generic Name for the trade name drug Ducord®.
What is the Manufacturer’s Name of Ducord®?
Ducord® is manufactured by Duke University School of Medicine.
Is Ducord® approved by the FDA?
Yes, Ducord® is approved by the FDA. Date of first approval: 03 October 2012.
What is the dosage and form of Ducord® supplied?
Ducord® is supplied as a cryopreserved cell suspension in a sealed bag containing a minimum of 9 x 108 total nucleated cells with a minimum of 1.25 x 106 viable CD34+ cells in a volume of 25 milliliters for IV use.
What are the most common side effects of Ducord® (HPC, Cord Blood)?
The most common infusion-related side effects of Ducord® are hypertension, bradycardia, vomiting, nausea, and fever.
How much does Ducord® (HPC, Cord Blood) cost in India?
Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on the cost of Ducord (HPC, Cord Blood) in India, it is recommended that you Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
Can Ducord® (HPC, Cord Blood) be available in SAARC countries?
Apart from Gulf countries, Ducord can be available in SAARC countries (India, Afghanistan, Bangladesh, Bhutan, Maldives, Nepal, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of the medicine Ducord in these countries, ensuring access to this therapeutic drug through legal and reliable channels.
What are the storage conditions of Ducord® (HPC, Cord Blood)?
Store Ducord® (HPC, Cord Blood) at or below -150 °C until ready for thawing and preparation.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.